Generate a tailored SOP for Dr. Antoni Ribas. Improve your application with a focused, well-structured draft.
Antoni Ribas is a physician-scientist at UCLA with a focus on malignant melanoma, conducting both laboratory and clinical research. His work includes translational research in adoptive cell transfer therapy, T-cell receptor engineered lymphocytes, and the interaction of immune therapies with malignant diseases. Ribas has pioneered studies on PD-1 blocking antibodies and has conducted extensive research into novel targeted therapies for melanoma, aiming to understand mechanisms of resistance and improve patient outcomes. He serves as the Director of the Parker Institute for Cancer Immunotherapy at UCLA and has made significant contributions to the understanding of cancer immunotherapy.
UCLA • Los Angeles, CA
Professor at UCLA in the Department of Medicine, leading research in melanoma and cancer immunotherapy.
Department of Economics admits primarily for the PhD program.